This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Learn when to harvest losses in index funds to optimize your tax outcome. This intro explains timing factors, safe harbors, and how to avoid wash-sale pitfalls.
14,223 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Mozilla’s latest security push uses Mythos AI to slash a year of fixes into one month, highlighting how AI-assisted d...
A first-year NFL player turns a nine-million-dollar rookie deal into a multi-million savings plan. The story highligh...
Family of a FSU victim files a federal lawsuit alleging the chatgpt developer sued over enabling the attacker. The ca...
Abcellera's Q1 2026 earnings transcript provides key clues about the path to 2026. This guide breaks down revenue dri...
IonQ delivers a standout Q1 and a fresh price-target outlook that signals potential triple-digit gains over the next ...
Independent consultants are increasingly using Solo 401(k) plans for their side gigs to shelter more income from taxe...
A new Pew poll shows Democrats and Republicans share a growing worry about the federal debt, a rare bipartisan moment...
Stellantis stands at a defining juncture. A strategic call on brand focus and EV spending could reshape profitability...
When a rising rapper faced a life-or-death verdict, the courtroom moment captured the nation. But beyond the headline...
A lithium-focused startup has joined the unicorn club after a surge in demand for EV batteries. The move signals a br...
Hyperliquid's AQAv2 upgrade pushes HYPE higher as Coinbase and Circle commit to the new stablecoin framework, alignin...